Evidence map›Paper›PMID 40622422›Full record

ArticleCellular and molecular neurobiology2025

Molecular Consequences of a Missense PHF21A Variant, c.1285G > A, Associated With Syndromic Neurodevelopmental Disorder.

Cecilia M Gavilan, Yumie Murata-Nakamura, Robert Porter, Bradley Cutler, Sehj Rai, Hyung-Goo Kim, Shigeki Iwase

Abstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cecilia M GavilanDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Yumie Murata-NakamuraDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Robert PorterDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Bradley CutlerDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Sehj RaiDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Hyung-Goo KimDepartment of Neurosurgery, Robert Wood Johnson Medical School, the State University of New Jersey, Piscataway NJ, Rutgers, 08854, USA.
Shigeki IwaseDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. siwase@umich.edu.

Funding

A Neuron-specific Methyl-histone Regulatory ComplexR01NS116008 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shigeki Iwase · 2020 to 2026
$3.6M
Career Training in Reproductive BiologyT32HD079342 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Suzanne M MOENTER · 2014 to 2026
$2.3M
Dissecting Histone H3K4 Methylation Enzymes in NeuroplasticityR01MH133632 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shigeki Iwase, Michael Mark Alexander Sutton · 2024 to 2026
$2.0M
Exploring Neuron - Specific Histone Methylation DynamicsR21NS104774 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI IWASE, SHIGEKI · 2018 to 2019
$429k
NICHD NIH HHS T32 HD079342NIH Awards R01MH133632NIMH NIH HHS R01 MH133632NINDS NIH HHS R01 NS116008NINDS NIH HHS R21 NS104774
6 · The paper itself

Abstract

PHF21A is a histone reader protein that recognizes unmethylated H3 lysine 4 and binds to DNA through its AT-hook motif. PHF21A heterozygosity is associated with intellectual disability, behavioral issues, and craniofacial dysmorphism, with or without seizures (IDDBCS), also known as PHF21A-related neurodevelopmental disorders. To date, the only missense variant associated with PHF21A-related disorders is c.1285G > A, which substitutes one of the core amino acids consisting of the AT-hook motif. This variant, located at the last nucleotide of exon 13, potentially disrupts both alternative splicing and the DNA binding function, providing a unique opportunity to investigate the molecular mechanisms underlying the disorders. Here, we systematically investigated the consequences of this variant on mRNA splicing and DNA binding. Our results indicate that the variant significantly reduced the splicing efficiency of PHF21A isoforms while maintaining DNA binding capability. Thus, reduced dosage rather than impaired DNA binding likely contributes to the cognitive impairments seen in the individual with this variant.

Indexed as

Mutation, MissenseNeurodevelopmental DisordersAlternative SplicingDNAHumansDNA

Identifiers

PMID40622422
PMCPMC12234916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.